What is it with India and diabetes trials gone wrong?
In two words, the answer, IMO, is protocol violations. Type-2 diabetes is a really, really big problem in India (#msg-13297601); the investigators must be under enormous pressure to bend the rules.
Market Data 
Markets 
AI
